HCPCS code J0651 — Inj, levothyroxine, freskabi. Status: Active. Effective Jul 1, 2024. Source: CMS HCPCS Level II.

J0651

Active

Inj, levothyroxine, freskabi

Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2024
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 0734

MUE — Medically Unlikely Edits

Maximum units of J0651 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 100
Outpatient Hospital 100
Practitioner Services 100

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
63323-0885-10 Levothyroxine Sodium
63323-0885-12 Levothyroxine Sodium
63323-0885-14 Levothyroxine Sodium
63323-0890-10 Levothyroxine Sodium
63323-0895-10 Levothyroxine Sodium

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q3
    Inj, levothyroxine, freskabi